Skip to main content
Breaking News
Feature Story

Time to just say no

An Open Letter to the Biopharmaceutical Industry and Its Investors

We can't believe it's 2016 and we have to spend our time writing this letter.

This year during JPMorgan week in San Francisco there was yet another cocktail party in which inappropriately clad women served as eye candy.

This time it was the LifeSci Advisors After Party, where young, female models were brought in to escort the guests on buses to the Exploratorium and to mingle with the crowd.

Read Article

Today's Biotech & Pharma News

  • THE DISTILLERY brings you this week's most essential scientific findings in therapeutics, distilled by Innovations editors from a weekly review of more than 400 papers in 41 of the highest-impact journals in the fields of biotechnology, the life sciences and chemistry. The Distillery goes beyond the abstracts to explain the commercial relevance of featured research, including licensing status and companies working in the field, where applicable.

    This week in therapeutics includes important research findings on targets and compounds, grouped first by disease class and then alphabetically by indication.

    This week in techniques includes findings about research tools, disease models and manufacturing processes that have the potential to enable or improve all stages of drug discovery and development.

Subscribe Now
Free Trial